Detalhe da pesquisa
1.
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
Br J Haematol
; 192(1): 62-74, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449159